Share on StockTwits

Express Scripts Holding Company (NASDAQ:ESRX) VP Keith J. Ebling sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $75.50, for a total transaction of $755,000.00. Following the completion of the sale, the vice president now directly owns 23,122 shares of the company’s stock, valued at approximately $1,745,711. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of research firms have recently commented on ESRX. Analysts at Cowen and Company cut their price target on shares of Express Scripts Holding Company from $77.00 to $76.00 in a research note on Thursday, July 31st. They now have a “market perform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Express Scripts Holding Company in a research note on Wednesday, July 30th. They now have a $71.00 price target on the stock. Finally, analysts at Jefferies Group cut their price target on shares of Express Scripts Holding Company from $86.00 to $80.00 in a research note on Wednesday, July 30th. They now have a “buy” rating on the stock. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Express Scripts Holding Company currently has a consensus rating of “Buy” and an average price target of $79.78.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded down 0.19% on Tuesday, hitting $75.08. 2,778,270 shares of the company’s stock traded hands. Express Scripts Holding Company has a 1-year low of $59.20 and a 1-year high of $79.37. The stock’s 50-day moving average is $69.92 and its 200-day moving average is $71.74. The company has a market cap of $55.968 billion and a price-to-earnings ratio of 33.61.

Express Scripts Holding Company (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $25.11 billion for the quarter, compared to the consensus estimate of $24.42 billion. During the same quarter in the previous year, the company posted $1.12 earnings per share. The company’s revenue for the quarter was down 4.8% on a year-over-year basis. Analysts expect that Express Scripts Holding Company will post $4.88 EPS for the current fiscal year.

Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.